FDA Clearance Tracker · P030004
ONYX LIQUID EMBOLIC SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 21, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Jul 21, 2005
Approved
Time to decision
856 days
Received Mar 18, 2003. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P030004
- Device name
- ONYX LIQUID EMBOLIC SYSTEM
- Applicant
- Ev3 Neurovascular
- Applicant location
- Irvine, CA
- Received
- Mar 18, 2003
- Decided
- Jul 21, 2005
- Decision
- Approved
- Supplements
- 41 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Agent, injectable, embolic (MFE)
- Device class
- Class III
- Specialty
- Neurology & Neurosurgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ONYX LIQUID EMBOLIC SYSTEM (LES). THE DEVICE IS INDICATED FOR PRESURGICAL EMBOLIZATION OF BRAIN ARTERIOVENOUS MALFORMATIONS.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MFE (Agent, injectable, embolic).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Ev3 Neurovascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Onyx Liquid Embolic System (LES)PMA supplement
P030004-S035 · Decided Dec 8, 2025 · 419 days after receipt · Panel Track
Device type: Neurovascular Liquid Embolic Agent (SGU) · Neurology & Neurosurgery
K241388 · Decided Jan 2, 2025 · 232 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K243418 · Decided Dec 2, 2024 · 28 days after receipt
Device type: Apparatus, Suction, Ward Use, Portable, Ac-Powered (JCX) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.